Skip to main content
. 2015 Aug 19;75:191–195. doi: 10.1016/j.biopha.2015.07.016

Table 1.

The demographic and clinical characteristics of patients.

Parameters Control Patients
Age 49.5 ± 3.1 50.5 ± 2.7
Male (%) 55% 45%
BMI (kg/m2) 23.9 ± 2.3 24.7 ± 4.3
CRP (mg/L) 2.14 ± 0.41 4.9 ± 0.63*
ESR (mm/h) 4.12 ± 0.71 24 ± 6.9*
FIB (g/L) 1.72 ± 0.63 4.2 ± 0.9*
WBC (109/L) 5.4 ± 2.1 5.7 ± 2.7
Adiponectin (μg/mL) 11.23 ± 3.2 6.5 ± 1.4*
FICAT staging NA III–IV
Index of FHC NA 0.34 ± 0.12

BMI, body mass index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cell counts; FIB, fibrinogen; FHC, femoral head collapse; NA, not applicable.

*

< 0.05.